Follow
Asaf Zviran
Asaf Zviran
C2i Genomics
Verified email at c2i-genomics.com
Title
Cited by
Cited by
Year
Derivation of novel human ground state naive pluripotent stem cells
O Gafni, L Weinberger, AAF Mansour, YS Manor, E Chomsky, ...
Nature 504 (7479), 282-286, 2013
11762013
Deterministic direct reprogramming of somatic cells to pluripotency
Y Rais, A Zviran, S Geula, O Gafni, E Chomsky, S Viukov, AAF Mansour, ...
Nature 502 (7469), 65-70, 2013
6452013
The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming
AAF Mansour, O Gafni, L Weinberger, A Zviran, M Ayyash, Y Rais, ...
Nature 488 (7411), 409-413, 2012
4162012
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
A Zviran, RC Schulman, M Shah, STK Hill, S Deochand, CC Khamnei, ...
Nature medicine 26 (7), 1114-1124, 2020
2472020
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
DA Landau, C Sun, D Rosebrock, SEM Herman, J Fein, M Sivina, ...
Nature communications 8 (1), 2185, 2017
1752017
Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors
I Maza, I Caspi, A Zviran, E Chomsky, Y Rais, S Viukov, S Geula, ...
Nature biotechnology 33 (7), 769-774, 2015
1492015
Neutralizing Gatad2a-Chd4-Mbd3/NuRD complex facilitates deterministic induction of naive pluripotency
N Mor, Y Rais, D Sheban, S Peles, A Aguilera-Castrejon, A Zviran, ...
Cell stem cell 23 (3), 412-425. e10, 2018
692018
Deterministic somatic cell reprogramming involves continuous transcriptional changes governed by Myc and epigenetic-driven modules
A Zviran, N Mor, Y Rais, H Gingold, S Peles, E Chomsky, S Viukov, ...
Cell Stem Cell 24 (2), 328-341. e9, 2019
502019
Control of fork-join networks in heavy traffic
R Atar, A Mandelbaum, A Zviran
2012 50th Annual Allerton Conference on Communication, Control, and …, 2012
362012
Acute myeloid leukemia iPSCs reveal a role for RUNX1 in the maintenance of human leukemia stem cells
J Wesely, AG Kotini, F Izzo, H Luo, H Yuan, J Sun, M Georgomanoli, ...
Cell reports 31 (9), 2020
352020
Deep learning mutation prediction enables early stage lung cancer detection in liquid biopsy
ST Kothen-Hill, A Zviran, RC Schulman, S Deochand, F Gaiti, D Maloney, ...
222018
Genotype-fitness maps of EGFR-mutant lung adenocarcinoma chart the evolutionary landscape of resistance for combination therapy optimization
PO Bolan, A Zviran, L Brenan, JS Schiffman, N Dusaj, A Goodale, ...
Cell systems 10 (1), 52-65. e7, 2020
112020
Lucky iPSCs
A Zviran, JH Hanna
Genome biology 15, 1-5, 2014
102014
Fork-join networks in heavy traffic: Diffusion approximations and control
A Zviran
Technion-Israel Institute of Technology, Faculty of Industrial and …, 2011
72011
Mbd3/NuRD is a key inhibitory module during the induction and maintenance of naïve pluripotency
A Zviran, Y Rais, N Mor, N Novershtern, JH Hanna
biorxiv, 013961, 2015
52015
Simulation of patients routing from an emergency department to internal wards in Rambam hospital
Y Tseytlin, A Zviran
OR Graduate Project, IE&M, Technion, 2008
52008
Ultra-sensitive detection of minimal residual disease (MRD) through whole genome sequencing (WGS) using an AI-based error suppression model in resected early-stage non-small …
AC Tan, SP Saw, GG Lai, KL Chua, A Takano, BH Ong, TP Koh, A Jain, ...
Cancer Research 82 (12_Supplement), 5114-5114, 2022
42022
Ultra-sensitive detection of circulating tumor dna through genome-wide integration
DA Landau, A Zviran, S Kothen-hill
US Patent App. 16/976,056, 2021
42021
Systems and methods for detection of residual disease
DA Landau, A Zviran, VA Adalsteinsson
US Patent App. 16/976,036, 2021
42021
Genome-wide cell-free DNA mutation integration for sensitive cancer detection
A Zviran, ST Hill, R Schulman, M Shah, S Deochand, G Ha, S Reed, ...
Cancer Research 78 (13_Supplement), 3247-3247, 2018
42018
The system can't perform the operation now. Try again later.
Articles 1–20